Naruse Hitomi, Sakamoto Yoshimasa, Kinouchi Katsushi, Inoue Takahiro, Matsumura Yoko, Yoshitake Michio, Bando Ko, Hashimoto Kazuhiro
Department of Cardiac Surgery, Jikei University School of Medicine, Tokyo, Japan.
Kyobu Geka. 2016 Jul;69(7):508-10.
A 41-year-old female with hereditary deficiency of antithrombin III (ATIII) was diagnosed with atrial septal defect( ASD) and scheduled for the closure of ASD. She had been taking warfarin since she suffered from deep vein thrombosis 10 years ago. Preoperative management of anticoagulation included discontinuation of warfarin, and supplementation of antithrombin with heparin infusion. On the day of operation, antithrombin activity was maintained above 80% by administering antithrombin, and closure of ASD was carried out under standard cardiopulmonary bypass support using heparin. Heparin infusion was continued with antithrombin supplementation until prothrombin time-international normalized ratio(PT-INR) recovered to around 2.5 with warfarin. Her intra-and postoperative courses did not show any thromboembolic events, and she was discharged 20 days after the surgery.
